Description

2-[(4-Bromo-3,5-Dimethyl-1H-Pyrazol-1-Yl)Methyl]Quinoline-4-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of complex active molecules. This compound is valued for its unique molecular architecture, which serves as a critical building block in medicinal chemistry and drug discovery programs. It is primarily utilized by research institutions and pharmaceutical manufacturers developing novel therapeutic agents.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly in oncology and anti-infective research.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery.
• Chemical Synthesis: Serves as a versatile building block for constructing complex heterocyclic compounds with potential biological activity.
• Bioconjugation & Probe Development: Can be utilized in the development of chemical probes and diagnostic agents due to its functionalizable quinoline core.
• Agrochemical Research: Investigated as an intermediate for developing new crop protection agents with specific modes of action.

Basic Information

Product Name	2-[(4-Bromo-3,5-Dimethyl-1H-Pyrazol-1-Yl)Methyl]Quinoline-4-Carboxylic Acid
CAS No.	956392-62-4
Molecular Formula	C₁₆H₁₄BrN₃O₂
Molecular Weight	360.21 g/mol
Synonyms	4-Quinolinecarboxylic acid, 2-[(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-; 2-((4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)methyl)quinoline-4-carboxylic acid; 956392-62-4; Quinoline-4-carboxylic acid, 2-[(4-bromo-3,5-dimethyl-1H-pyrazol-1-yl)methyl]-; 2-[(4-Bromo-3,5-dimethylpyrazol-1-yl)methyl]quinoline-4-carboxylic acid
EINECS	Contact for details

Quality Control

Our production of 2-[(4-Bromo-3,5-Dimethyl-1H-Pyrazol-1-Yl)Methyl]Quinoline-4-Carboxylic Acid adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the exacting standards required for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with every shipment to guarantee traceability, consistency, and compliance with your specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider conditions under an inert atmosphere to ensure optimal stability.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.